AUDGPI Research Collaboration Meeting: Programme Grants Tuesday February 6

advertisement

AUDGPI Research

Collaboration Meeting:

Programme Grants

Tuesday February 6 th , 2007

Andrew W Murphy

Department of General Practice,

NUI, Galway

1

Format

Time Topic

1100 Intro

1105 Cochrane Primary Hlth

Care Field

1120 Discussion

1200 Programme grants

1215 Discussion

1300 Lunch

1400 Research networks

1415 Discussion

1500 Finish

Discussant

AW Murphy

T Fahey

AW Murphy

TC O’Dowd

2

Objectives

• To outline experience of SPHERE programme grant

• To stimulate discussion regarding 2007 programme grant applications

– potential topics

– potential partners

3

The SPHERE Study

Randomised controlled trial of an intervention for primary care to increase secondary prevention of coronary heart disease

M Byrne,, M Cupples, AW Murphy, S Smith

4

The SPHERE Study

RCT of a behavioural intervention for primary care, to improve secondary prevention of coronary heart disease

(CHD)

Baseline Irish data indicated room for improvement

(Byrne & Murphy, 2002)

Recent review of trials – optimal intervention still elusive

(McAlister, 2001)

5

Programme objectives

Primary

– To design, implement and evaluate a multifaceted intervention to improve both the process of care and objective clinical outcomes for patients with established ischaemic heart disease in general practice.

Secondary

– To perform a qualitative analysis of the development and delivery of the intervention.

– To perform a health economic analysis of the intervention in the Republic of Ireland and Northern Ireland.

– To perform a policy analysis of the context within which the intervention is delivered in the Republic of Ireland and Northern

6

Ireland.

Developing RCTs of complex interventions

Preclinical phase:

Theory

Phase I:

Modelling

Phase II:

Exploratory trial

Phase III:

Definitive

Randomised

Controlled

Trial

Phase IV:

Long-term

Implementation

Continuum of increasing evidence

Campbell et al . BMJ 2000; 321(7262):694-6.

7

SPHERE Graphical depiction

Time

Perera BMJ 334:127

SPHERE Usual Care line intervention (control)

Baseline bac cba a a

Randomisation

(time 0)

During 18 months from randomisati on f de gh d e g h f b c b c

Measurement of outcomes

18 months

8

Reflections on SPHERE programme grant

9

Workload

10

Quality and range of staff

Date Position Name

01.09.04 -

01.03.03 -

01.01.07 -

15.01.07 -

01.12.06 -

01.09.06 -

01.10.04 -

Project Manager Mary Byrne

Principal Research

Nurse

Claire Leathem

Regional Research

Nurse

Regional Research

Nurse

Helen Grealish

Patricia Ryan

Qualitative Researcher

(50%)

Qualitative/Policy

Researcher

Maureen D’Eath

Joanne Wilson

Economics PhD student Paddy Gillespie

11

Date

Staff turnover

Position

01.01.03 - 30.06.04

Project Manager

01.06.04 – 15.12.06

Regional Research

Nurse

Name

Molly Byrne

Mary O’Malley

01.01.06 – 05.01.07

Regional Research

Nurse

01.06.04 – 30.11.05

Regional Research

Nurse

Valerie Spillane

Ailish Houlihan

01.04.03 – 30.04.04

Qualitative

Researcher (40%)

Pauline Clerkin

01.01.03 – 28.02.05

Qualitative

Researcher (50%)

Publications

• Corrigan M, Cupples ME, Smith SM, Byrne M, Leathem C,

Clerkin P, Murphy AW. The contribution of qualitative research in designing a complex intervention for secondary prevention of coronary heart disease in two different healthcare systems.

BMC Health Services Research 2006; 6:90

• Byrne M, Cupples ME, Smith SM, Leathem C, Corrigan M,

Byrne MC, Murphy AW.

Development of a complex intervention for secondary prevention of coronary heart disease in primary care using the UK Medical Research Council

framework. Am Journal of Managed Care2006;12:261-266

• Murphy AW, Cupples ME, Smith S, Byrne M, Leathem C, Byrne

MC. The SPHERE Study. Secondary prevention of heart disease in general practice: protocol of a randomised controlled trial of tailored practice and patient care plans with parallel qualitative, economic and policy analyses.

[ISRCTN24081411].

Current Controlled Trials in

Cardiovascular Medicine 2005. Jul 29;6(1):11

• Byrne M, Corrigan M, Cupples ME, Smith SM, Leathem C,

Murphy AW. The SPHERE study: Using psychological theory to inform the development of behaviour change training for primary care staff to increase secondary prevention of

coronary heart disease. Irish Journal of Psychology 2005;

26(1-2):53-64.

13

Publications: indirect

• Murphy AW, Esterman A, Pilotto L. Cluster randomised

controlled trials in primary care: an introduction. EJGP

12(2): 70-73, 2006.

• Pirkis JE, Blashki GA, Murphy AW, Richards JC, Hickie

IB, Ciechomski L. The contribution of general practice based research in the development of national policy:

case studies from Ireland and Australia. Australia and

New Zealand Health Policy 2006; 3:4.

• Byrne M, Murphy AW, Walsh J, Shryane E, McGroarty M,

Kelleher CC. A cross sectional study of secondary cardiac care in general practice: Impact of personal and

practice characteristics. Fam Prac 2006; 23: 295-302

• Ononeze V, Murphy AW, Byrne M, Bradley C, MacFarlane

A. Patients and health professionals' perspectives on the sociocultural influences on secondary cardiac behaviour: a qualitative study of the implications in policy and

practice. Fam Prac 23: 587 – 596, 2006

14

Further reflections

• Lancet protocol accepted

• Zero use of Masters/ PhD’s

• Probably the most rewarding and enjoyable collaborative academic exercise I have been involved in

• Explicit strategic ‘07 departmental goal

15

Objectives

• To outline experience of SPHERE programme grant

• To stimulate discussion regarding 2007 programme grant applications

– potential topics

– potential partners

16

HRB grants

• Translational research

– € 1.5 million over five years

• Health services R&D

– € 1.25 million over five years

• Both:

– Call date August; Closing date 07 (EoI)

– To be confirmed

17

Health services R&D

• Support research which is related to the day-to-day

practice of health service staff and is capable of showing a demonstrable impact on the health or

health care of users of the service.

• Funded research projects are likely to fall into the areas of health service and systems research and public

health research, although other areas are not excluded from the programme.

• Research proposals should use quantitative or qualitative methods to:

– study the provision and use of services;

– evaluate the effectiveness and cost effectiveness of interventions;

– examine the resource utilisation of alternative means for healthcare delivery;

– formally scrutinise innovations and

developments;

18

Health services R&D, not

• This programme will not fund:

– laboratory-based research or basic science research, including research based on animals

– proposals which are solely service developments: although the programme will fund research aimed at evaluating the effectiveness of a service or intervention it will not fund the costs of providing the service or intervention itself

– proposals which are solely: literature reviews, audit, surveys, needs assessment, technology development (although these elements may be part of an integrated research study) 19

Funded examples

• Susan Smith: Diabetes and peer support

• ?

20

Translational research

is defined as research that applies ideas, insights and discoveries generated through basic scientific inquiry to the treatment or prevention of human disease.

The purpose of these awards is to

support the development of clinical research

improve outcomes for patients by establishing and supporting teams working full time on extensive research programmes with clear link to patients

contribute to the creation of intellectual property and the development of bio-industry by using scientific or technical knowledge to produce new or substantially improved materials, devices, products or

21 services.

Funded examples

• Reducing hospital infections caused by methicillin-resistant aureus and

Staphylococcus vancomycin-resistant enterococci by effective environmental decontamination and effective hand hygiene

• Neurocardiovascular influences on cognitive functioning: basic and clinical mechanisms

22

Discussion

• Potential topics

– What, if any, areas have you ambitions for in 2007 ?

– NUI, Galway: eGFR

• Potential partners

– Whom, if anybody, would you like to work with ? In and out of primary care ?

23

Kaplan-Meier risk of CVS composite end point according to baseline eGFR, Glynn07

Hazard Function

0.4

0.2

eGFR category

<30ml/min

>59ml/min

30-44ml/min

45-59ml/min

No serum creatinine data

<30ml/min-censored

>59ml/min-censored

30-44ml/mincensored

45-59ml/mincensored

No serum creatinine data-censored

0.0

0 500 1000

Time (days)

1500 2000

24

Download